Literature DB >> 30902900

Negligible Role for Deletion Mediated by cDC1 in CD8+ T Cell Tolerance.

Brendan W MacNabb1, Douglas E Kline1, Annie R Albright2, Xiufen Chen2, Daniel S Leventhal3, Peter A Savage1,3,4, Justin Kline5,2,3.   

Abstract

Deletion of CD8+ T cells by dendritic cells (DCs) is recognized as a critical mechanism of immune tolerance to self-antigens. Although DC-mediated peripheral deletion of autoreactive CD8+ T cells has been demonstrated using T cells reactive to model Ags, its role in shaping the naturally occurring polyclonal CD8+ T cell repertoire has not been defined. Using Batf3-/- mice lacking cross-presenting CD8α+ and CD103+ DCs (also known as type 1 conventional [cDC1]), we demonstrate that peripheral deletion of CD8+ T cells reactive to a model tissue Ag is dependent on cDC1. However, endogenous CD8+ T cells from the periphery of Batf3-/- mice do not exhibit heightened self-reactivity, and deep TCR sequencing of CD8+ T cells from Batf3-/- and Batf3+/+ mice reveals that cDC1 have a minimal impact on shaping the peripheral CD8+ T cell repertoire. Thus, although evident in reductionist systems, deletion of polyclonal self-specific CD8+ T cells by cDC1 plays a negligible role in enforcing tolerance to natural self-ligands.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30902900      PMCID: PMC6478510          DOI: 10.4049/jimmunol.1801621

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Constitutive class I-restricted exogenous presentation of self antigens in vivo.

Authors:  C Kurts; W R Heath; F R Carbone; J Allison; J F Miller; H Kosaka
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

2.  Identification of Natural Regulatory T Cell Epitopes Reveals Convergence on a Dominant Autoantigen.

Authors:  John D Leonard; Dana C Gilmore; Thamotharampillai Dileepan; Wioletta I Nawrocka; Jaime L Chao; Mary H Schoenbach; Marc K Jenkins; Erin J Adams; Peter A Savage
Journal:  Immunity       Date:  2017-07-11       Impact factor: 31.745

3.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Authors:  Miranda L Broz; Mikhail Binnewies; Bijan Boldajipour; Amanda E Nelson; Joshua L Pollack; David J Erle; Andrea Barczak; Michael D Rosenblum; Adil Daud; Diane L Barber; Sebastian Amigorena; Laura J Van't Veer; Anne I Sperling; Denise M Wolf; Matthew F Krummel
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

4.  Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation.

Authors:  Bryan Vander Lugt; Aly A Khan; Jason A Hackney; Smita Agrawal; Justin Lesch; Meijuan Zhou; Wyne P Lee; Summer Park; Min Xu; Jason DeVoss; Chauncey J Spooner; Cecile Chalouni; Lelia Delamarre; Ira Mellman; Harinder Singh
Journal:  Nat Immunol       Date:  2013-12-22       Impact factor: 25.606

5.  Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells.

Authors:  Allison W Roberts; Bettina L Lee; Jacques Deguine; Shinu John; Mark J Shlomchik; Gregory M Barton
Journal:  Immunity       Date:  2017-11-14       Impact factor: 31.745

6.  WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Authors:  Derek J Theisen; Jesse T Davidson; Carlos G Briseño; Marco Gargaro; Elvin J Lauron; Qiuling Wang; Pritesh Desai; Vivek Durai; Prachi Bagadia; Joshua R Brickner; Wandy L Beatty; Herbert W Virgin; William E Gillanders; Nima Mosammaparast; Michael S Diamond; L David Sibley; Wayne Yokoyama; Robert D Schreiber; Theresa L Murphy; Kenneth M Murphy
Journal:  Science       Date:  2018-11-09       Impact factor: 63.714

7.  Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation.

Authors:  Alena M Gallegos; Michael J Bevan
Journal:  J Exp Med       Date:  2004-10-18       Impact factor: 14.307

8.  Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.

Authors:  Kai Hildner; Brian T Edelson; Whitney E Purtha; Mark Diamond; Hirokazu Matsushita; Masako Kohyama; Boris Calderon; Barbara U Schraml; Emil R Unanue; Michael S Diamond; Robert D Schreiber; Theresa L Murphy; Kenneth M Murphy
Journal:  Science       Date:  2008-11-14       Impact factor: 47.728

9.  MHC class I cross-presentation by dendritic cells counteracts viral immune evasion.

Authors:  Katrin Nopora; Caroline A Bernhard; Christine Ried; Alejandro A Castello; Kenneth M Murphy; Peggy Marconi; Ulrich Koszinowski; Thomas Brocker
Journal:  Front Immunol       Date:  2012-11-26       Impact factor: 7.561

10.  Rapid chromatin repression by Aire provides precise control of immune tolerance.

Authors:  Andrew S Koh; Erik L Miller; Jason D Buenrostro; David M Moskowitz; Jing Wang; William J Greenleaf; Howard Y Chang; Gerald R Crabtree
Journal:  Nat Immunol       Date:  2018-01-15       Impact factor: 25.606

View more
  3 in total

Review 1.  Trial watch: dendritic cell vaccination for cancer immunotherapy.

Authors:  Jenny Sprooten; Jolien Ceusters; An Coosemans; Patrizia Agostinis; Steven De Vleeschouwer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2019-07-18       Impact factor: 8.110

2.  Type 2 cytokines in the thymus activate Sirpα+ dendritic cells to promote clonal deletion.

Authors:  Elise R Breed; Matouš Vobořil; Katherine M Ashby; Ryan J Martinez; Lily Qian; Haiguang Wang; Oscar C Salgado; Christine H O'Connor; Kristin A Hogquist
Journal:  Nat Immunol       Date:  2022-05-30       Impact factor: 31.250

Review 3.  Mechanisms of Direct and Indirect Presentation of Self-Antigens in the Thymus.

Authors:  Jiří Březina; Matouš Vobořil; Dominik Filipp
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.